Replies to post #457003 on Anavex Life Sciences Corp (AVXL)

[boi568]

See next message.

[boi568]

Missling has indicated it has been accepted, but of course the time line isn't working.

I would consider this a more critical matter if CHMP hadn't already cleared an MAA.

[crescentmotor]

We don't even know if the promised journal article has been accepted anywhere.

The April 2024 Corporate Presentation states "Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal". To me, that certainly implies that an article has been accepted. I suppose a more cynical view is that the statement only expresses AVXL's intentions. The SEC filings don't address a journal article at all so far as I remember.